Shoichi Hazama

Summary

Affiliation: Yamaguchi University
Country: Japan

Publications

  1. ncbi Efficacy of orally administered superfine dispersed lentinan (beta-1,3-glucan) for the treatment of advanced colorectal cancer
    Shoichi Hazama
    Department of Surgery II, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi 755 8505, Japan
    Anticancer Res 29:2611-7. 2009
  2. ncbi Improvement of QOL and prognosis by treatment of superfine dispersed lentinan in patients with advanced gastric cancer
    Shigefumi Yoshino
    Department of Surgery II, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan
    Hepatogastroenterology 57:172-7. 2010
  3. ncbi Suppressive effects of cyclophosphamide and gemcitabine on regulatory T-cell induction in vitro
    Shin Kan
    Department of Digestive Surgery and Surgical Oncology, Yamaguchi University Graduate School of Medicine, 1 1 1 Minami kogushi, Ube City, Yamaguchi Prefecture, 755 8505, Japan
    Anticancer Res 32:5363-9. 2012
  4. ncbi Impact of chemotherapy for colorectal cancer on regulatory T-cells and tumor immunity
    Kazunari Maeda
    Department of Digestive Surgery and Surgical Oncology, Yamaguchi University Graduate School of Medicine, 1 1 1 Minamikogushi, Ube City, Yamaguchi Prefecture 755 8505, Japan
    Anticancer Res 31:4569-74. 2011
  5. ncbi Phase I study of irinotecan and doxifluridine for metastatic colorectal cancer focusing on the UGT1A1*28 polymorphism
    Shoichi Hazama
    Department of Digestive Surgery and Surgical Oncology Surgery II, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan
    Cancer Sci 101:722-7. 2010
  6. ncbi The importance of evaluation of DNA amplificability in KRAS mutation testing with dideoxy sequencing using formalin-fixed and paraffin-embedded colorectal cancer tissues
    Naoko Okayama
    Division of Laboratory, Yamaguchi University Hospital, Ube, Yamaguchi, Japan
    Jpn J Clin Oncol 41:165-71. 2011

Collaborators

Detail Information

Publications6

  1. ncbi Efficacy of orally administered superfine dispersed lentinan (beta-1,3-glucan) for the treatment of advanced colorectal cancer
    Shoichi Hazama
    Department of Surgery II, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi 755 8505, Japan
    Anticancer Res 29:2611-7. 2009
    ..To investigate the safety and effectiveness of SDL, a multi center clinical study in patients with advanced colorectal cancer was conducted...
  2. ncbi Improvement of QOL and prognosis by treatment of superfine dispersed lentinan in patients with advanced gastric cancer
    Shigefumi Yoshino
    Department of Surgery II, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan
    Hepatogastroenterology 57:172-7. 2010
    ..Recently, superfine dispersed lentinan--an oral formulation--has become clinically available. In order to evaluate the efficacy of superfine dispersed lentinan, was conducted multicenter clinical study...
  3. ncbi Suppressive effects of cyclophosphamide and gemcitabine on regulatory T-cell induction in vitro
    Shin Kan
    Department of Digestive Surgery and Surgical Oncology, Yamaguchi University Graduate School of Medicine, 1 1 1 Minami kogushi, Ube City, Yamaguchi Prefecture, 755 8505, Japan
    Anticancer Res 32:5363-9. 2012
    ..Inhibition of CD4(+)FOXP3(+) regulatory T-cell (Treg) activity may be important for successful cancer immunotherapy. We investigated the suppressive effects of several chemotherapeutic agents on Treg induction in vitro...
  4. ncbi Impact of chemotherapy for colorectal cancer on regulatory T-cells and tumor immunity
    Kazunari Maeda
    Department of Digestive Surgery and Surgical Oncology, Yamaguchi University Graduate School of Medicine, 1 1 1 Minamikogushi, Ube City, Yamaguchi Prefecture 755 8505, Japan
    Anticancer Res 31:4569-74. 2011
    ..The purpose of the present study was to determine how oxaliplatin plus infusional 5-fluorouracil and leucovorin (FOLFOX) and irinotecan plus infusional 5-fluorouracil and leucovorin (FOLFIRI) affect Tregs and other immune effectors...
  5. ncbi Phase I study of irinotecan and doxifluridine for metastatic colorectal cancer focusing on the UGT1A1*28 polymorphism
    Shoichi Hazama
    Department of Digestive Surgery and Surgical Oncology Surgery II, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan
    Cancer Sci 101:722-7. 2010
    ..The gene polymorphism should be considered when determining the precise recommended doses to be administered in phase I studies...
  6. ncbi The importance of evaluation of DNA amplificability in KRAS mutation testing with dideoxy sequencing using formalin-fixed and paraffin-embedded colorectal cancer tissues
    Naoko Okayama
    Division of Laboratory, Yamaguchi University Hospital, Ube, Yamaguchi, Japan
    Jpn J Clin Oncol 41:165-71. 2011
    ..We evaluated DNA amplificability to achieve a 100% success rate in KRAS mutation testing with dideoxy sequencing using formalin-fixed and paraffin-embedded colorectal cancer tissue samples obtained from a recent clinical trial...